Literature DB >> 32384473

Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life.

Muhammet Ozer1,2, Goksel Bengi3, Rumeysa Colak1, Ozan Cengiz3, Hale Akpinar3.   

Abstract

Irritable bowel syndrome (IBS)-like symptoms tend to be common in inflammatory bowel disease (IBD) patients even during the long-standing remission phase, and quality of life (QOL) seem to reduce in IBD patients with such symptoms. Thus, the aim of this study was to define the prevalence of IBS-like symptoms in inactive IBD patients using Rome IV criteria and evaluate the effect of IBS-like symptoms on QOL.Total 137 patients with IBD (56 with ulcerative colitis (UC) and 81 with Crohn disease (CD), who had been in long-standing remission according to the clinical scoring system and 123 control participants were included. These patients completed questionnaires to evaluate IBS-like symptoms according to Rome IV criteria, and the impact of these symptoms on the QOL of inactive IBD patients was compared with and without IBS-like symptoms according to disease-specific inflammatory bowel disease questionnaire (IBDQ).Depending on our research, IBS-like symptoms were found in 32% (18/56) of patients with inactive UC, 35% (29/81) of patients with inactive CD, and 13.8% (17/123) of control participants (P < .001). The QOL seemed to be significantly lower in both inactive UC and CD patients with IBS-like symptoms than in those without such symptoms (P < .001).In conclusion, we defined that the prevalence of IBS-like symptoms in IBD patients in remission is 2 to 3 times higher than that in healthy control participants, and significantly lower IBDQ scores showed QOL was reduced in inactive IBD patients with IBS-like symptoms as compared with patients without IBS-like symptoms.

Entities:  

Mesh:

Year:  2020        PMID: 32384473      PMCID: PMC7220554          DOI: 10.1097/MD.0000000000020067

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  35 in total

1.  The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases.

Authors:  N A CHAUDHARY; S C TRUELOVE
Journal:  Q J Med       Date:  1962-07

Review 2.  Changes in enteric neural circuitry and smooth muscle in the inflamed and infected gut.

Authors:  G M Mawe; S M Collins; T Shea-Donohue
Journal:  Neurogastroenterol Motil       Date:  2004-04       Impact factor: 3.598

3.  Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health.

Authors:  Forough Farrokhyar; John K Marshall; Brock Easterbrook; E Jan Irvine
Journal:  Inflamm Bowel Dis       Date:  2006-01       Impact factor: 5.325

4.  Validation of the Dutch translation of the Inflammatory Bowel Disease Questionnaire (IBDQ): a health-related quality of life questionnaire in inflammatory bowel disease.

Authors:  M G Russel; C J Pastoor; S Brandon; J Rijken; L G Engels; D M van der Heijde; R W Stockbrügger
Journal:  Digestion       Date:  1997       Impact factor: 3.216

5.  Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors.

Authors:  Magnus Simrén; Jenny Axelsson; Rolf Gillberg; Hasse Abrahamsson; Jan Svedlund; Einar S Björnsson
Journal:  Am J Gastroenterol       Date:  2002-02       Impact factor: 10.864

6.  Irritable bowel syndrome in general practice: prevalence, characteristics, and referral.

Authors:  W G Thompson; K W Heaton; G T Smyth; C Smyth
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

7.  Previous inflammation alters the response of the rat colon to stress.

Authors:  S M Collins; K McHugh; K Jacobson; I Khan; R Riddell; K Murase; H P Weingarten
Journal:  Gastroenterology       Date:  1996-12       Impact factor: 22.682

8.  Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.

Authors:  M Vivinus-Nébot; G Frin-Mathy; H Bzioueche; R Dainese; G Bernard; R Anty; J Filippi; M C Saint-Paul; M K Tulic; V Verhasselt; X Hébuterne; T Piche
Journal:  Gut       Date:  2013-07-22       Impact factor: 23.059

9.  Ulcerative colitis and irritable bowel syndrome: relationships with quality of life.

Authors:  Reza Ansari; Fatemeh Attari; Hadi Razjouyan; Arash Etemadi; Hiva Amjadi; Shahin Merat; Reza Malekzadeh
Journal:  Eur J Gastroenterol Hepatol       Date:  2008-01       Impact factor: 2.566

10.  Characterization of IBS-like symptoms in patients with ulcerative colitis in clinical remission.

Authors:  B Jonefjäll; H Strid; L Ohman; J Svedlund; A Bergstedt; M Simren
Journal:  Neurogastroenterol Motil       Date:  2013-06-04       Impact factor: 3.598

View more
  1 in total

1.  Mucosal healing and quality of life in therapeutic goals of ulcerative colitis: occurrence and related factors of functional bowel disorder-like symptoms.

Authors:  Lihui Lin; Tianqi Wang; Yaming Lu; Peng Chen; Yingfan Zhang; Xiaoman Zu; Baili Chen; Ren Mao; Rui Feng; Yi Cui; Shenghong Zhang; Yao He
Journal:  Therap Adv Gastroenterol       Date:  2022-04-29       Impact factor: 4.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.